AUCTA宣布其氨己烯酸散剂在中国与复星医药签署上市销售许可
July 25, 2019 00:01 ET
|
Aucta Pharmaceuticals, Inc.
新泽西州,皮斯卡塔韦, July 25, 2019 (GLOBE NEWSWIRE) -- Aucta Pharmaceuticals, Inc.(Aucta)是一家专注从事品牌专业产品开发 与商业化的科技企业。近日,该公司宣布已与 上海复星医药(集团)股份有限公司(以下称“复星医药”)控股子公司江苏万邦生化医...
AUCTA宣布其氨己烯酸散劑在中國與復星醫藥簽署上市銷售許可
July 25, 2019 00:01 ET
|
Aucta Pharmaceuticals, Inc.
新澤西州,皮斯卡塔韋, July 25, 2019 (GLOBE NEWSWIRE) -- Aucta Pharmaceuticals, Inc.(Aucta)是一家專注從事品牌專業產品開發 與商業化的科技企業。近日,該公司今天宣布已與上海復星醫藥(集團)股份有限公司(以下稱“復星醫藥”)下屬的控股子公司江蘇萬 邦生化醫藥股份有限公司簽署排他性許可協議(以下稱“協議”) ...
Aucta Pharmaceuticals Announces Licensing of Vigabatrin for Oral Solution in China
July 25, 2019 00:01 ET
|
Aucta Pharmaceuticals, Inc.
PISCATAWAY, N.J., July 25, 2019 (GLOBE NEWSWIRE) -- Aucta Pharmaceuticals, Inc. (Aucta), a technology based company focusing on the development and commercialization of Branded Specialty Products,...
Aucta Pharmaceuticals宣布就拉莫三嗪新药申请授予许可
June 27, 2019 08:00 ET
|
Aucta Pharmaceuticals, Inc.
新泽西州PISCATAWAY, June 27, 2019 (GLOBE NEWSWIRE) -- Aucta Pharmaceuticals, Inc. (Aucta)是一家拥有特有技术平台的产品公司,公司致力于专科领域品牌产品的研发和商业化。该公司今天宣布已与Eton Pharmaceuticals, Inc.签订协议,将AUC025在美国市场的销售权给予Eton...
Aucta Pharmaceuticals 宣佈就拉莫三嗪新藥申請授予許可
June 27, 2019 08:00 ET
|
Aucta Pharmaceuticals, Inc.
新澤西州,PISCATAWAY, June 27, 2019 (GLOBE NEWSWIRE) -- Aucta Pharmaceuticals, Inc. (Aucta)是一家擁有特有技術平臺的產品公司,公司致力於專科領域品牌產品的研發和商業化。該公司今天宣佈已與Eton Pharmaceuticals, Inc.簽訂協定,將AUC025在美國市場的銷售權給予Eton...
Aucta Pharmaceuticals Announces Licensing of Lamotrigine New Drug Application
June 27, 2019 08:00 ET
|
Aucta Pharmaceuticals, Inc.
PISCATAWAY, N.J., June 27, 2019 (GLOBE NEWSWIRE) -- Aucta Pharmaceuticals, Inc. (Aucta), a technology based company focusing on the development and commercialization of Branded Specialty Products,...
Aucta Pharmaceuticals及Oakrum Pharma宣佈將進行產品開發和商業化合作
February 19, 2019 08:00 ET
|
Aucta Pharmaceuticals, Inc.
美國新澤西州北布倫瑞克, Feb. 19, 2019 (GLOBE NEWSWIRE) -- Aucta Pharmaceuticals, Inc. (Aucta) 今天宣佈其已與Oakrum Pharma, LLC (Oakrum) 達成一項協議,將開發並生產四種擬在美國以Oakrum商標進行商業化的處方仿製藥產品。 預計這些產品將供應予零售市場,包括口服液和局部用藥。...
Aucta Pharmaceuticals和Oakrum Pharma宣布将进行产品开发和商业化合作
February 19, 2019 08:00 ET
|
Aucta Pharmaceuticals, Inc.
北布伦瑞克,新泽西州, Feb. 19, 2019 (GLOBE NEWSWIRE) -- Aucta Pharmaceuticals, Inc.(Aucta)今天宣布其已与Oakrum Pharma,...
Aucta Pharmaceuticals and Oakrum Pharma Announce Product Development and Commercialization Partnership
February 19, 2019 08:00 ET
|
Aucta Pharmaceuticals, Inc.
NORTH BRUNSWICK, N.J., Feb. 19, 2019 (GLOBE NEWSWIRE) -- Aucta Pharmaceuticals, Inc. (Aucta) announced today that it has entered into an agreement with Oakrum Pharma, LLC (Oakrum) to develop and...
Aucta Receives its First Product Approval and Launches Vigabatrin for Oral Solution Under the Brand Name Vigadrone™
July 16, 2018 08:00 ET
|
Aucta Pharmaceuticals, Inc.
NEW BRUNSWICK, N.J., July 16, 2018 (GLOBE NEWSWIRE) -- Aucta Pharmaceuticals, Inc. (Aucta) announced today that it has begun shipping Vigabatrin for Oral Solution, USP, 500 mg, following final...